Recently, the results of a systematic review on the clinical effectiveness and cost-effectiveness of home telemonitoring (TM) or structured telephone support (STS) strategies were published. Both strategies were compared with usual care for adult patients who have been recently discharged (within 28 days) from acute care after a recent exacerbation of HF.
Highlights of the conclusions were:
- Compared with usual care, remote monitoring was beneficial in reducing all-cause mortality;
- A sensitivity analysis showed larger beneficial effects for most outcomes, particularly for telemonitoring during office hours;
- Telemonitoring during office hours was the most cost-effective strategy with an estimated incremental cost-effectiveness ratio of £11,873 per quality-adjusted life-year compared with usual care.
To us as a telemedicine company the results did not really come as a surprise, and we will continue our journey of letting these solutions serve as many patients as possible.